Welcome to the Indiana Hemophilia & Thrombosis Center.
The IHTC was established in 1998 by Amy D. Shapiro, M.D., the center's co-medical director and pediatric hematologist, and Anne Greist, M.D., the center's co-medical director and adult hematologist. The center is located at the St. Vincent Hospital campus in Indianapolis, Indiana. Patient care, research and education are the focus of the center. Yet at the heart of all we do is patient care, as our mission statement indicates:
The Indiana Hemophilia & Thrombosis Center Inc. is committed to providing the highest quality comprehensive healthcare services to patients with bleeding and clotting disorders, and to their families.
Click here to view current open positions.
School Educator Program
Click here to watch our educational videos designed for school staff members
The IHTC is first of its kind to receive national quality certification!
The Indiana Hemophilia and Thrombosis Center (IHTC), Indiana’s only federally recognized Hemophilia Treatment Center, is the first Hemophilia Treatment Center in the U.S. to become a certified medical home by the Accreditation Association for Ambulatory Health Care (AAAHC). This certification recognizes excellence in quality patient-centered health care for organizations that provide medical care on an outpatient basis.
Kenyan Doctor Visits the IHTC
The IHTC hosts Dr. Mwaniki, Medical Officer with AMPATH, from Kenya in August.
Dr. Shapiro receives research award
Dr. Shapiro receives the 2015 St. Vincent Health Research Symposium Career Achievement in Research Award.
FDA Approves Emergent’s New rFIX Therapy!
In late April, Emergent BioSolutions, Inc., announced that the US Food and Drug Administration (FDA) has approved IXINITY®, the company’s recombinant factor IX (rFIX) product.